PeptidePedia The community reference

Triple agonist: difference between revisions

Diff·revision 25 → 26·07:52, 13 Mar 2026

Difference between revision 25 and revision 26 of Triple agonist. This revision changed no lines of source — the edit was a null or whitespace change.

Revision 25 — 21:46, 9 Feb 2026
CuriousCallum (talk)
add the year of first marketing authorisation, with the regulator named
4,269 bytes ±0
Revision 26 — 07:52, 13 Mar 2026
SubQ_Solveig (talk)
the half-life in the lead was the terminal figure; label it as such
4,269 bytes ±0
No change to the page source.